Come See What's New at ASH this year

INVENTIV HEALTH HAS HELPED DEVELOP AND COMMERCIALIZE 80% OF ONCOLOGY DRUGS APPROVED BY THE FDA.*

Please join me and our experienced team at this year's American Society of Hematology (ASH) December 5th - 8th in Orlando this year.   We invite you to meet with team of experts in oncology trials, immunotherapy research, and commercialization of oncology assets.

INVENTIV HEALTH IS A LEADER IN ONCOLOGY AND IMMUNOTHERAPY RESEARCH

? Phase I and early phase experience in multiple indications with integrated services including bioanalytics
? Conducted over 300 hematology and oncology projects in the past five years
? Unmatched immuno-oncology experience:
o Over 10,000 patients treated in a wide range of immune therapies including vaccines and immuno-checkpoint inhibitors
o Helped develop and commercialize two of the three immuno-oncology drugs approved by the FDA currently on the market

To Learn More, visit inVentivHealth.com/Clinical  

*In the past 5 years